Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Earlier this month, researchers at Harvard University published the results of their recent study, which observed an increased risk of nonarteritic anterior ischemic optic neuropathy (NAION) in patients taking semaglutide for type 2 diabetes or weight loss
Consult with a healthcare professional if you have any concerns or questions
If a person on tirzepatide develops any of these gastrointestinal complications, they need immediate hospitalization and emergency medical care
58 The challenge in determining the optimal duration of GLP-1 RA therapy is further complicated by the observed weight regain upon discontinuation of treatment
So to back up, the traditional model, which I think most understand of how pharma makes money, selling drugs to wholesalers, wholesalers sell that to pharmacies, pharmacies get reimbursed by PBMs
